1075-00-9 Usage
Description
8-Fluoroisoquinoline is a synthetic, organic compound belonging to the isoquinoline group of chemicals. It is distinguished by the presence of a fluorine atom at the 8th position of the isoquinoline structure, which endows it with unique properties and structural characteristics. 8-Fluoroisoquinoline serves as a versatile building block in complex chemical syntheses, particularly in research and development.
Uses
Used in Pharmaceutical Research and Development:
8-Fluoroisoquinoline is utilized as a key intermediate in the synthesis of various pharmaceuticals, including antitumor and antiviral agents. Its unique structure and properties make it a valuable component in the development of new drugs with potential therapeutic applications.
Used in the Creation of Functional Materials:
Beyond its pharmaceutical applications, 8-Fluoroisoquinoline is also employed in the design and synthesis of functional materials. Its chemical properties and structural features contribute to the development of materials with specific characteristics, such as improved stability, reactivity, or selectivity, depending on the intended application.
The exact properties of 8-Fluoroisoquinoline, such as its melting point, boiling point, or solubility, can vary depending on the presence of additional functional groups attached to its core structure. This variability allows for the fine-tuning of its properties to suit specific applications in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 1075-00-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,0,7 and 5 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1075-00:
(6*1)+(5*0)+(4*7)+(3*5)+(2*0)+(1*0)=49
49 % 10 = 9
So 1075-00-9 is a valid CAS Registry Number.
InChI:InChI=1/C9H6FN/c10-9-3-1-2-7-4-5-11-6-8(7)9/h1-6H
1075-00-9Relevant articles and documents
SUBSTITUTED ARYLMETHYLUREAS AND HETEROARYLMETHYLUREAS, ANALOGUES THEREOF, AND METHODS USING SAME
-
Page/Page column 296; 297, (2020/07/07)
The present invention includes substituted arylmethyl ureas and heteroarylmethyl-ureas, and compositions comprising the same, that can be used to treat or prevent hepatitis B virus (HBV) infections in a patient.
ALDOSTERONE SYNTHASE INHIBITORS
-
Page/Page column 59; 60, (2012/11/13)
This invention relates to tricyclic triazole analogues of the formula I or their pharmaceutically acceptable salts, wherein the variable are defined herein. The inventive compounds selectively inhibit aldosterone synthetase. This invention also provides for pharmaceutical compositions comprising the compounds of Formula I or their salts as well as to methods for the treatment, amelioration or prevention of conditions that could be treated by inhibiting aldosterone synthetase.
Synthesis of novel substituted isoquinolones
Briet, Nicolas,Brookes, Michael H,Davenport, Richard J,Galvin, Frances C.A,Gilbert, Philip J,Mack, Stephen R,Sabin, Verity
, p. 5761 - 5766 (2007/10/03)
A series of novel substituted isoquinolones have been synthesised. This has been achieved by two routes, either Curtius rearrangment of cinnamic acids or via an isoquinoline N-oxide.